Volume 13, Number 9—September 2007
HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan
|HCV prevalence||107 (36.8)|
|Higher educational level||0.51 (0.29–0.88)|
|Ever shared needle or syringe||2.60 (1.71–3.96)|
|Duration injection drug use >3 y||3.28 (2.17–4.96)|
|Injections by a nonmedical provider||2.71 (1.26–5.82)|
*HCV, hepatitis C virus. Values are no. (%) or adjusted odds ratio (95% confidence interval). Analysis was adjusted for marital status, educational level, duration of injecting, sharing needles or syringes, and injections by a nonmedical provider.